Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,622 | -25,100 | -10,652 | -105,032 | -76,734 |
| Depreciation Amortization | 3,107 | 1,961 | 887 | 4,023 | 3,045 |
| Accounts payable and accrued liabilities | N/A | 2,206 | N/A | 3,492 | 1,251 |
| Other Working Capital | 1,324 | 1,184 | -54 | 7,209 | 3,799 |
| Other Operating Activity | 7,512 | -3,011 | -1,420 | 37,533 | 24,713 |
| Operating Cash Flow | $-36,679 | $-22,760 | $-11,239 | $-52,775 | $-43,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,019 | -2,582 | -1,333 | -2,902 | -742 |
| Investing Cash Flow | $-3,019 | $-2,582 | $-1,333 | $-2,902 | $-742 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 22,699 | 11,149 | 10,000 | 5,600 | 5,600 |
| Debt Repayment | N/A | N/A | N/A | -5,489 | N/A |
| Common Stock Issued | 1,598 | 1,566 | 248 | 20,570 | 19,451 |
| Other Financing Activity | 14,046 | 8,505 | 2,334 | 21,287 | 5,566 |
| Financing Cash Flow | $38,343 | $21,220 | $12,582 | $41,968 | $30,617 |
| Exchange Rate Effect | 487 | -1,419 | -784 | 5,505 | 8,307 |
| Beginning Cash Position | 6,965 | 6,965 | 6,965 | 15,169 | 15,169 |
| End Cash Position | 6,097 | 1,424 | 6,191 | 6,965 | 9,425 |
| Net Cash Flow | $-868 | $-5,541 | $-774 | $-8,204 | $-5,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,679 | -22,760 | -11,239 | -52,775 | -43,926 |
| Capital Expenditure | -3,019 | -2,582 | -1,333 | -2,902 | -742 |
| Free Cash Flow | -39,698 | -25,342 | -12,572 | -55,677 | -44,668 |